Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The company returns high margins, thereby supporting business profitability.
The group usually releases upbeat results with huge surprise rates.
Its low valuation, with P/E ratio at 5 and 3.62 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Most analysts recommend that the stock should be sold or reduced.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.